Claims Appeals banner - coverage Access support
Billing and Coding
|Product package code|
|NDC||00517-0650-01||Injectafer (ferric carboxymaltose injection) 750 mg iron/15 mL single-use vial (individually boxed)|
|Product-specific billing code|
|HCPCS||J1439||Injection, ferric carboxymaltose, 1 mg|
|Drug administration codes|
|Therapeutic, prophylactic, or diagnostic injection (specify substance or drug) Intravenous push single or initial substance drug
Intravenous infusion for therapy, prophylaxis, or diagnosis (specify substance or drug); initial up to 1 hr
Abbreviations: CPT, Current Procedural Terminology; FARS/DFARS, Federal Acquisition Regulation/Defense Federal Acquisition Regulation Supplement; HCPCS, Healthcare Common Procedure Coding System; NDC, National Drug Code.
We recommend verifying the coding policies for each individual health plan. Access Central Coordinators can provide information relating to payer-specific policies and can address other questions at 1-866-4-DSI-NOW.
Examples of IDA-related diagnosis codes
|Primary diagnosis codes (ICD-10-CM)|
|D50.0||Iron deficiency anemia secondary to blood loss (chronic)|
|D50.8||Other iron deficiency anemias|
|D50.9||Iron deficiency anemia, unspecified|
|D63.0||Anemia in neoplastic disease
CODE NEOPLASM FIRST (Confirm iron deficiency)
|D63.1||Anemia in chronic kidney disease
CODE CKD STAGE FIRST (Confirm iron deficiency)
|D63.8||Anemia in other chronic diseases
classified elsewhere CODE UNDERLYING DISEASE FIRST (Confirm iron deficiency)
|D63.81||Antineoplastic chemotherapy-induced anemia (Confirm iron deficiency)|
Other codes may be appropriate.
A code specific for your IDA patient’s underlying condition†
|Codes related to IDA patient’s underlying condition (ICD-10-CM)|
|K50.0-K50.919||Crohn's disease [regional enteritis]|
|K90.4||Malabsorption due to intolerance not elsewhere classified|
|K90.9||Intestinal malabsorption unspecified|
|N18.1||Chronic kidney disease, stage 1|
|N18.2||Chronic kidney disease, stage 2|
|N18.30||Chronic kidney disease stage 3 unspecified|
|N18.31||Chronic kidney disease stage 3a|
|N18.32||Chronic kidney disease stage 3b|
|N18.4||Chronic kidney disease, stage 4|
|N18.5||Chronic kidney disease, stage 5|
|N18.6||End-stage renal disease|
|N18.9||Chronic kidney disease, unspecified|
|N92.0||Excessive and frequent menstruation with regular cycle|
|N92.5||Other specified irregular menstruation|
|N92.6||Irregular menstruation, unspecified|
|T45.4X5A||Adverse effect of iron and its compounds, initial encounter|
|T50.905A||Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter|
*A joint effort between the healthcare provider and the coder is essential to achieve complete and accurate documentation, code assignment, and reporting of diagnoses and procedures. This information is provided to assist both the healthcare provider and the coder in identifying potential diagnoses. The importance of consistent, complete documentation in the medical record cannot be overemphasized. Without such documentation, accurate coding cannot be achieved. The entire record should be reviewed to determine the specific reason for the encounter and the conditions treated.
†Secondary code suggestions only; appropriate codes not limited to those listed above. Injectafer is indicated to treat IDA; it is not indicated to treat the above listed underlying conditions. Some listed diagnosis codes may indicate a subcategory and be nonbillable. For reporting purposes, only codes with the full number of required characters are permissible.
Abbreviation: ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification.
We recommend verifying the coding policies for each individual health plan. Reimbursement specialists can provide information relating to payer-specific policies and can address other questions at 1-866-4-DSI-NOW.